mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.002 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.002 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.004 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.005 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.005 |